Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q3 2023 Earnings

14NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.37

-0.3

-0.22

-0.15

Details

Expected EPS

-0.22

Actual EPS

-0.21

Surprise EPS

0.01

Surprise Percent

+4.55%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.21 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.